Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: KTOS

Re: KTOS

in response to by
posted on Mar 31, 2009 06:36AM

Well at least it looks like we didn't pay much for the Vigilis Platform:

"The total aggregate cash consideration the Company expects to receive for these businesses is approximately $0.5 million".





SAX

Share
New Message
Please login to post a reply